Results 121 to 130 of about 202,126 (199)

Pathophysiology and Treatment of the No-Reflow Phenomenon in ST-Segment Elevation Myocardial Infarction: Focus on Low-Dose Fibrinolysis during Primary Percutaneous Intervention. [PDF]

Rev Cardiovasc Med, 2023
Pelliccia F, Niccoli G, Zimarino M, Andò G, Porto I, Calabrò P, De Rosa S, Gragnano F, Piccolo R, Moscarella E, Fabris E, Montone RA, Spaccarotella C, Indolfi C, Sinagra G, Filardi PP, Working Group of Interventional Cardiology of the Italian Society of Cardiology.   +16 more
europepmc   +1 more source

Breaking the Barrier: Unraveling the No-Reflow Phenomenon in Cardiovascular Medicine. [PDF]

Catheter Cardiovasc Interv
Howes S, Altaee O, Ramirez A, Calaquian L, Asif A, Stone C, Hammadah M, Roy D, Ramsey B, Chilton R.   +9 more
europepmc   +1 more source

Mechanisms of the "No-Reflow" Phenomenon After Acute Myocardial Infarction: Potential Role of Pericytes. [PDF]

JACC Basic Transl Sci, 2023
Kaul S, Methner C, Cao Z, Mishra A.
europepmc   +1 more source

The triglyceride-glucose index and neutrophil-to-lymphocyte ratio jointly predict the no-reflow phenomenon in T2DM patients with STEMI after primary PCI. [PDF]

PLoS One
Yang J, Xu D, Liu X, Zhao Z, Zhang J.
europepmc   +1 more source

Reversible No-Reflow Phenomenon in a Free Flap after 16 Hours.

Indian J Plast Surg, 2023
Babu SR, Malhotra A, Shah UA, Dandekar PB, Chindarkar HP, Doddi AK, Chakraborty SS.   +6 more
europepmc   +1 more source

Endothelial Activation and Stress Index (EASIX) as a novel index associated with no-reflow phenomenon in STEMI: a bi-center retrospective study. [PDF]

BMC Cardiovasc Disord
Faideci EM, Hancıoğlu E, Ziyrek M, Özcan S, Güzel S, Alak ME, Aslan R, Ardahanlı İ, Ertan Ç, Şahin İ, Okuyan E.   +10 more
europepmc   +1 more source

No reflow phenomenon in CAD patients after percutaneous coronary intervention: A prospective hospital based observational study. [PDF]

Indian Heart J, 2023
Rao S, Bhardwaj R, Negi PC, Nath RK.
europepmc   +1 more source

Association and Prognostic Implications of "No-Reflow Phenomenon" and Hypercoagulability in Patients With ST-Segment Elevation Myocardial Infarction. [PDF]

JACC Asia
Omar M, Kang MG, Jung MK, Ahn JH, Koh JS, Guevarra PI, Kim SW, Tantry US, Gurbel PA, Hwang JY, Jeong YH.   +10 more
europepmc   +1 more source

Pathophysiology, Diagnosis, and Management of Coronary No-Reflow Phenomenon. [PDF]

Int J Angiol, 2022
Kaur G, Baghdasaryan P, Natarajan B, Sethi P, Mukherjee A, Varadarajan P, Pai RG.   +6 more
europepmc   +1 more source

Advances in Pathophysiology and Novel Therapeutic Strategies for Coronary No-Reflow Phenomenon. [PDF]

Biomedicines
Borzuta H, Kociemba W, Bochenek O, Jarowicz M, Wsół A.   +4 more
europepmc   +1 more source